JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC
Clinical trial NCT07582822 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07582822
- Sponsor
- Biotech Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-30
- Primary completion
- 2028-05-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.